Major INAAT industry players include Tecan Genomics Inc., Eiken Chemical Co. Ltd, Hologic Inc. (Gen-Probe), Lucigen, Meridian Bioscience, Inc., OptiGene Limited, Qiagen NV, Quidel Corporation, and Grifols, S.A.
Selbyville, Delaware , April 20, 2022 (GLOBE NEWSWIRE) —

The isothermal nucleic acid amplification technology (INAAT) market value is projected to reach USD 2.8 billion by 2028, according to a new research report by Global Market Insights Inc. Increasing number of pathology labs and services equipped with advanced diagnostic systems will boost the industry expansion.
Ongoing technological advancements in the healthcare industry will fuel the market demand. Various manufacturers in this market are building in-house capabilities to develop high-quality test kits with quick turnaround times to fulfil a variety of research needs. Besides, the increased demand for cutting-edge sample amplification, extraction, and preparation methods will drive the market development. The demand for these test kits for RNA and DNA identification is also likely to increase. Furthermore, major manufacturers are partnering with several research institutes to co-develop novel test kits and support molecular biology research. Many new businesses are expected to enter this market to create new diagnostic products that are cost-effective and address the growing medical needs of consumers globally.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5251

INAAT market from nucleic acid sequence-based amplification (NASBA) segment surpassed USD 151.7 million in 2021. This is attributed to its increased usage in retroviral and microbial detection. Also, the NASBA system is based in part on RNA transcription for amplification, several copies of RNA are transcribed in each (theoretical) cycle. As a result, the augmented kinetics of the NASBA process is intrinsically more efficient than PCR amplification.

Some major findings of the isothermal nucleic acid amplification technology market report include:
Rising prevalence of chronic and infectious diseases worldwide will propel the business landscape.
Increasing demand for cost-effective and rapid testing is proving beneficial for the INAAT industry.
Growing popularity for point of care testing will accelerate the market progression.
Government funding and rising R&D activities to develop fully automated diagnostic instruments will foster the market share.

Browse key industry insights spread across 160 pages with 235 market data tables & 14 figures & charts from the report, “Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecasts By Technology (Loop-mediated Isothermal Amplification [LAMP], Helicase-dependent Amplification [HDA], Nucleic Acid Sequence-based Amplification [NASBA], Strand Displacement Amplification [SDA]), By Product (Instruments, Reagents), Application, (Infectious Disease {HIV, Influenza, Malaria, Tuberculosis}, Oncology, Blood Screening), End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market

Isothermal nucleic acid amplification technology market from instruments segment accounted for around 28% revenue share in 2021. This is owing to increasing diagnostic testing for various infections and chronic diseases. Also, growing number of authorized diagnostic laboratories and rising worldwide elderly population will propel the segment revenue. Further, the developments and innovation in various test kits and growing demand for user-friendly, diagnostic tests will enhance the industry size.
The oncology segment held over 5% revenue share in 2021. This is attributed to surging cases of cancer globally. For instance, according to national cancer institute, in 2020, an estimated 1.8 million new cancer cases in the U.S. were projected by the organization. Thus, to avoid such scenarios, screening and diagnosis of disease plays a crucial role. For instance, INAAT technology LAMP assay is highly used in cancer detection. Such scenarios will spur the market expansion.
The hospital segment the isothermal nucleic acid amplification technology market is anticipated to exhibit 11.4% CAGR during the projected timeline. This is owing to strong requirement of INAAT kits and instruments in hospital settings. Also, in hospitals the chances of preanalytical error of sampling, inappropriate specimen transport can be avoided. Such positive scenarios will stimulate the business outlook. Furthermore, hospitals are well equipped with advanced equipment along the presence of trained medical professionals. As a result, patients prefer hospitals for any type of diagnosis for better care thereby, fostering the overall market progression.
Asia Pacific isothermal nucleic acid amplification technology market held around 19% business share in 2021. Several Asia Pacific countries such as Japan, India, and China, are witnessing increasing demand for diagnostic tests due to increasing geriatric population and surging prevalence of infectious diseases such as tuberculosis in the region. The market growth is also supported by presence of independent diagnostic center chains, hospitals, and academic institutes. Furthermore, growing demand for cost-effective diagnostics coupled with less stringent regulatory scenarios will augment the regional market outlook.
Request for customization of this research report @ https://www.gminsights.com/roc/5251

Some of the key market leaders operating in the isothermal nucleic acid amplification technology industry include BD, Abbott (Alere), BioMerieux SA, Eiken Chemical Co. Ltd, Hologic Inc. (Gen-Probe), Lucigen, Meridian Bioscience, Inc., OptiGene Limited, Qiagen NV, Quidel Corporation, Tecan Genomics Inc., Grifols, S.A., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Ltd.
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Rowan Street Capital LLC, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be seen here. The past two quarters have been difficult for all growth investors and certainly for Rowan Street partners. COVID reopening, inflation, the threat of a rapid increase in interest rates as well as […]
Yahoo Finance Live’s Julie Hyman and Brian Sozzi discuss first quarter earnings for Netflix.
Yahoo Finance's Brian Sozzi and Julie Hyman discuss Netflix stock cratering after nine Wall Street analysts downgraded shares after the streaming giant reported earnings.
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts. You can skip our analysis of the pharmaceutical industry and go directly to Analysts Are Downgrading These 5 Pharmaceutical Stocks. The pharmaceutical industry always remains in focus as investors scramble to find innovative companies working on treatments of diseases. The […]
Yahoo Finance’s Pras Subramanian joins the Live show to discuss earnings expectations for Tesla.
Yahoo Finance Live’s Julie Hyman and Brian Sozzi discuss IBM stock.
PayPal is the largest digital platform that provides money transfer services. The fast-growing company remains one of the high-profile stocks in today's stock market. But is PayPal stock a buy in the current stock market rally? PayPal boasts a consistent track record of earnings and sales growth, stretching back to at least 2010.
The world's biggest iron ore producer shipped 15% less iron ore in the first three months of 2022.
In this article, we discuss 8 stocks to sell now according to Mitch Cantor’s Mountain Lake Investment Management. If you want to skip our detailed analysis of Cantor’s history, investment philosophy, and hedge fund performance, go directly to 4 Stocks to Sell Now According to Mitch Cantor’s Mountain Lake Investment Management. California-based hedge fund Mountain […]
Today is shaping up negative for AT&T Inc. ( NYSE:T ) shareholders, with the analysts delivering a substantial negative…
PayPal (NASDAQ: PYPL) shareholders have experienced the best and worst in just a few short years. Much has changed since then — PayPal shares are down 63% in the past six months versus a 1.9% decline in the S&P 500. PayPal's steep pullback grabbed my attention from the start — how does the world's largest mobile payments company shed over half of its value in such a short period of time?
Yahoo Finance Live’s Julie Hyman and Brian Sozzi discuss third quarter earnings for Procter & Gamble.
There’s plenty of talk around about the dreaded ‘R’ word, recession, as the markets are obviously cooling off following the prolonged bull runs of late 2020 and 2021. With inflation running at 40-year highs, and GDP growth slipping in Q1, it’s no wonder that people are talking about a return to the late ‘70s, and Carter-era economic malaise. But have we taken the pessimism too far? Covering the market situation for Wells Fargo, senior equity analyst Chris Harvey believes so. He sums up the forec
As Netflix searches for new subscribers amid a big downturn, the streaming giant is looking to end password sharing.
Analysts expected Netflix to add millions of subscribers in the first quarter, but it lost 200,000 instead. The stock is down more than 25%, and the streaming giant confirmed this is not a blip, it’s an existential crisis.
Regeneron's buyout of Checkpoint Pharmaceuticals is sparking a rally among clinical-stage cancer research companies today.
Is Sundial Growers (NASDAQ: SNDL) a cannabis cultivator that moonlights as a marijuana investment bank, or vice versa? As interesting as Sundial's hybrid business model may be, the stock's future depends on convincing investors that it's more than a meme. All eyes will be on Sundial's forthcoming earnings report describing its performance in the fourth quarter and for all of 2021.
Rowan Street Capital LLC, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be seen here. The past two quarters have been difficult for all growth investors and certainly for Rowan Street partners. COVID reopening, inflation, the threat of a rapid increase in interest rates as well as […]
(Bloomberg) — Russia’s state oil producing giant Rosneft PJSC surprised traders in Europe and Asia with offers to sell large amounts of crude at speed, as well as setting out significant changes to the payment process for at least some of the cargoes.Most Read from BloombergKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineNetflix Breaks Its Own Rules After Subscriber Losses Batter SharesIn Defense of Elon Musk's Managerial ExcellenceUkrainian Troops Risk Being Encircled in Ne
Rowan Street Capital LLC, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be seen here. The past two quarters have been difficult for all growth investors and certainly for Rowan Street partners. COVID reopening, inflation, the threat of a rapid increase in interest rates as well as […]

source

Leave a Reply

Your email address will not be published.